Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| EDB-HF2G4 | Human | Fluorescent Human EDNRB Full Length Protein (VLP) |
|
||
| EDB-H52P7 | Human | Human EDNRB Full Length Protein (VLP) |
|
Immobilized Human EDNRB Full Length Protein-VLP (Cat. No. EDB-H52P7) at 5 μg/mL (100 μL/well) can bind Anti-EDNRB Antibody, Human IgG1 with a linear range of 0.1-2 ng/mL (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Sovateltide | IRL-1620; PMZ-1620; SPI-1620 | Approved | University Of Illinois At Chicago | Tyvalzi | India | Stroke | Pharmazz Inc | 2023-05-31 | Biliary Tract Neoplasms; Brain Ischemia; Carcinoma; Spinal Cord Injuries; Asphyxia Neonatorum; Brain Diseases; Stroke; Ischemic Stroke; Dementia; Alzheimer Disease; Hypoxia-Ischemia, Brain; Cerebral Infarction; Carcinoma, Non-Small-Cell Lung | Details |
| Macitentan/Tadalafil | Approved | Actelion Pharmaceuticals Ltd | OPSYNVI, Yuvanci | United States | Pulmonary Arterial Hypertension | Actelion Pharmaceuticals Us Inc | 2024-03-22 | Phenylketonurias; Pulmonary Arterial Hypertension | Details | |
| Bosentan Hydrate | ACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039 | Approved | F. Hoffmann-La Roche Ltd | Stayveer, 全可利, Tracleer | United States | Pulmonary Arterial Hypertension | Actelion Pharmaceuticals Ltd | 2001-11-20 | Hepatopulmonary Syndrome; Diabetes Mellitus; Heart Defects, Congenital; Anemia, Sickle Cell; Persistent Fetal Circulation Syndrome; Ulcer; Glaucoma; Sleep Apnea Syndromes; Pulmonary Arterial Hypertension; Coronary Vasospasm; Lung Diseases, Interstitial; Hypertension, Pulmonary; Pulmonary Fibrosis; Hypertension; Fibrosis; Chronic thromboembolic pulmonary hypertension; Liver Cirrhosis; Sarcoidosis; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Type 2; Heart Septal Defects, Atrial | Details |
| Macitentan | ACT-064992; Actelion-1; JNJ-67896062 | Approved | Actelion Pharmaceuticals Ltd | Zependo, Opsumit, 傲朴舒 | United States | Pulmonary Arterial Hypertension | Actelion Pharmaceuticals Us Inc | 2013-10-18 | Hypertension, Pulmonary; Pulmonary Embolism; Heart Failure, Diastolic; Heart Failure; Scleroderma, Systemic; Chronic thromboembolic pulmonary hypertension; Idiopathic Pulmonary Fibrosis; Glioblastoma; Thromboembolism; Pulmonary Arterial Hypertension; Eisenmenger Complex; Scleroderma-associated interstitial lung diseases; Ulcer; Heart Defects, Congenital; Anemia, Sickle Cell; Chronic Disease | Details |
| Aprocitentan | JNJ-2820; ACT-132577; AC-080 | Approved | Actelion Pharmaceuticals Ltd, Idorsia Pharmaceuticals Ltd | TRYVIO, JERAYGO | United States | Hypertension | Idorsia Pharmaceuticals Ltd | 2024-03-19 | Hypertension; Essential Hypertension; Hepatic Insufficiency; Renal Insufficiency, Chronic | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| VRP-1620 | VRP-1620 | Phase 3 Clinical | University Of Illinois | Breast Neoplasms | Details |
| Vodudeutentan | ENB-003; ENB-006 | Phase 2 Clinical | Enb Therapeutics Inc | Ovarian Neoplasms; Solid tumours; Pancreatic Neoplasms; Neoplasms; Melanoma | Details |
| BQ-788 | BQ-788 | Phase 1 Clinical | Merck Serono | Hypertension; Cardiovascular Diseases; Melanoma | Details |
This web search service is supported by Google Inc.
A-Z
